Relativity Logo
    Relativity
    Relativity Logo
    Relativity
    IdeasPortfolios
    Companies/ARQT

    Arcutis Biotherapeutics, Inc.(ARQT)

    Biotechnology
    Immunology & Autoimmune Biotech
    BusinessManagementInsider TradingIndustryFinancialsTranscripts
    Company Summary Stats
    H.BearBearishNeutralBullishH.Bull
    55.0
    Insider Trading Score
    Peer Group Scores
    REGN
    78
    LLY
    70
    JNJ
    57
    PFE
    56
    ARQT
    55
    ABBV
    50
    CHRS
    50
    AMGN
    47
    INCY
    34
    ACRS
    32
    PVLA
    10
    Recent Insider Trades
    Filing DateInsiderType10b5-1Net SharesOwnership changeAvg. PriceValueFiling
    2026-05-13
    Vairavan Latha
    SVP Chief Financial Officer
    Sale
    -435
    -0.50%85,978
    $21.05$9,157View SEC filing
    2026-05-13
    Burnett Patrick
    See Remarks
    Sale
    -222
    -0.18%120,244
    $21.05$4,673View SEC filing
    2026-05-06
    Vairavan Latha
    SVP Chief Financial Officer
    Sale
    -1,341
    -1.53%86,413
    $23.61$31,662View SEC filing
    2026-05-06
    Watanabe Todd
    See Remarks
    Sale
    -3,172
    -0.44%720,755
    $23.61$74,893View SEC filing
    2026-05-06
    Matsuda Masaru
    See Remarks
    Sale
    -8,256
    -6.12%126,689
    $23.31$192,415View SEC filing
    2026-05-06
    Burnett Patrick
    See Remarks
    Sale
    -684
    -0.56%120,466
    $23.61$16,150View SEC filing
    2026-05-05
    Welgus Howard G.
    Director
    Sale
    -7,144
    -17.98%32,600
    $22.99$164,220View SEC filing
    2026-04-03
    Welgus Howard G.
    Director
    Sale
    -10,000
    -20.10%39,744
    $23.88$238,801View SEC filing
    2026-03-04
    Leonard Keith R
    Director
    Sale
    -39,272
    -63.97%22,123
    $25.39$997,195View SEC filing
    2026-03-04
    Welgus Howard G.
    Director
    Sale
    -10,000
    -16.74%49,744
    $25.65$256,518View SEC filing
    2026-03-03
    Edwards Larry Todd
    See Remarks
    Sale
    -3,687
    -2.06%175,178
    $25.18$92,846View SEC filing
    2026-03-03
    Watanabe Todd
    See Remarks
    Sale
    -37,349
    -4.54%785,957
    $25.18$940,528View SEC filing
    2026-03-03
    Matsuda Masaru
    See Remarks
    Sale
    -12,058
    -6.85%136,932
    $26.03$313,877View SEC filing
    2026-03-03
    Vairavan Latha
    SVP Chief Financial Officer
    Sale
    -2,853
    -3.15%87,754
    $25.18$71,844View SEC filing
    2026-03-03
    Burnett Patrick
    See Remarks
    Sale
    -6,287
    -4.91%121,150
    $25.18$158,320View SEC filing
    2026-02-04
    Matsuda Masaru
    See Remarks
    Sale
    -40,638
    -26.98%110,003
    $25.28$1,027,293View SEC filing
    2026-02-04
    Burnett Patrick
    See Remarks
    Sale
    -13,469
    -14.31%80,651
    $25.72$346,455View SEC filing
    2026-02-04
    Watanabe Todd
    See Remarks
    Sale
    -19,833
    -2.68%721,306
    $25.50$505,710View SEC filing
    2026-02-04
    Vairavan Latha
    SVP Chief Financial Officer
    Sale
    -1,320
    -2.03%63,607
    $25.50$33,658View SEC filing
    2026-02-04
    Welgus Howard G.
    Director
    Sale
    -10,000
    -14.34%59,744
    $25.05$250,483View SEC filing
    2026-02-04
    Edwards Larry Todd
    See Remarks
    Sale
    -2,052
    -1.36%148,865
    $25.50$52,323View SEC filing
    2026-01-07
    Burnett Patrick
    See Remarks
    Sale
    -2,490
    -2.58%94,120
    $28.98$72,166View SEC filing
    2026-01-06
    Welgus Howard G.
    Director
    Sale
    -10,000
    -12.54%69,744
    $28.96$289,606View SEC filing
    2026-01-02
    Burnett Patrick
    See Remarks
    Sale
    -1,697
    -1.73%96,610
    $29.20$49,560View SEC filing
    2025-12-17
    Burnett Patrick
    See Remarks
    Sale
    -11,500
    -10.47%98,307
    $28.94$332,851View SEC filing

    1-25 of 251

    Page 1 of 11